As a member of the DSM team since 1994, Lubben is responsible for the global activities of the company’s Bio-Based Chemicals & Materials business – a group that brings together several global innovation teams focused on developing and commercializing renewable chemicals and downstream compounds. Lubben also serves as a board member of Reverdia, a large-scale facility for the commercial production of biobased succinic acid, which is a joint venture between DSM and Roquette.
“We are slowly, but certainly, starting the switch from a fossil-based to a bio-based economy,” said Lubben. “Still at an early stage, it is clear there is no such thing as a silver bullet approach to force your way in. At DSM we believe that a profound understanding of the value chain and the integral relationship between biomass, products and applications are the most important keys to success in this emerging industry.”
“With the knowledge and expertise Dr. Lubben has gained as a leader in the biotechnology industry and as part of the DSM team, he is one of the few people in his field who is in a position to know where industrial biotechnology is today and where it can go in the future,” said Larry Drumm, SCD-iBIO’s Executive Director. “We are honored to have Dr. Lubben share his insight and perspective on the future of our industry during our International Forum.”